M2 EQUITYBITES-August 26, 2015-Amedica announces silicon nitride lateral lumbar interbody
fusion device in the lumbar fusion market
Titan Spine established in 2006, aims on the design, manufacture and marketing of titanium interbody
cage devices that take part in the fusion process.
that will provide surgeons and hospitals in Europe with access to Amedica's interbody
spinal fusion devices made with silicon nitride.
Move Dramatically Increases the Market Size for the Company's Unique Osteogenic Spinal Interbody
M2 PHARMA-July 11, 2016-Titan Spine Secures CMS New Technology ICD-10 Code for Nanotextured Surface on Interbody
M2 EQUITYBITES-November 14, 2014-Integra LifeSciences wins FDA clearance and controlled market release for Integra Expandable Interbody
System in the US
Implants for surgery cervical disc herniation
3 billion global lumbar interbody
fusion market, according to the company.
The fastest growing spinal implant market segments are the minimally invasive surgery segments, MIS interbody
fusion and MIS thoracolumbar fixation, because of improved clinical outcomes and reduced surgical times for MIS procedures.
M2 PHARMA-July 1, 2016-Benvenue Medical Celebrates Milestone with Luna 3D Interbody
Fusion System Use
The company's hydrophilic and osteoconductive bioceramic is designed to facilitate bone growth in the center lumen of an interbody
spinal device, which should allow surgeons to reduce or eliminate the use of allograft bone and other osteoconductive biomaterials.
Salt Lake City, Utah-based Amedica Corporation, a spinal and reconstructive medical device manufacturer, has beefed up its executive management in preparation for efforts to shift the standard of care for interbody
fusion devices toward proprietary silicon nitride ceramic.